Pneumocystis IFA (Immunofluorescence Assay) is a laboratory test used to detect Pneumocystis jirovecii, a fungus that can cause Pneumocystis pneumonia (PCP), particularly in people with weakened immune systems. The test uses fluorescently labelled antibodies to identify the organism in an appropriate respiratory specimen. It is needed when Pneumocystis pneumonia is suspected, helping support diagnosis and guide timely treatment in high-risk individuals.
Pneumocystis jirovecii is a fungus that can cause pneumonia, particularly in people with significantly weakened immune systems, such as some individuals with HIV or those receiving immunosuppressive treatment.
PCP is a lung infection caused by Pneumocystis jirovecii. It can cause serious respiratory illness, especially in individuals whose immune systems are compromised.
IFA stands for Immunofluorescence Assay. It uses antibodies linked to fluorescent substances to help identify specific organisms under a specialized microscope.
A positive result indicates that Pneumocystis jirovecii organisms were detected in the tested specimen. The result should be interpreted alongside symptoms and other clinical findings.
A negative result means the organism was not detected by the test. However, a negative result does not always completely exclude infection, particularly when the specimen contains insufficient organisms.
No. IFA uses fluorescent antibodies to visualize the organism, while PCR detects its genetic material. The choice of test depends on the specimen, clinical situation, and laboratory availability.